Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B
- PMID: 36678401
- PMCID: PMC9861021
- DOI: 10.3390/pathogens12010054
Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B
Abstract
Interleukin-1 beta (IL-1β) promotes liver disease progression and hepatocarcinogenesis in chronic hepatitis B (CHB). Single nucleotide polymorphisms (SNPs) within the promotor region of the IL-1β gene can affect the progression towards liver cirrhosis and hepatocellular carcinoma (HCC). Aims: We aimed to investigate the association of three common IL-1β SNPs with hepatitis B virus (HBV)-related HCC in Caucasian patients. Method: A Caucasian cohort of 99 patients with HBe antigen (Ag)-positive CHB, 255 patients with HBeAg-negative CHB and 278 inactive carriers (IC) were enrolled. 105 patients were diagnosed with liver cirrhosis, and 64 with HCC and cirrhosis. Genotyping of the IL-1β rs1143623, rs1143627 and rs16944 was performed. Results: The rs1143627 TT and rs16944 CC genotypes were more frequent in patients with HCC compared to patients without liver tumours (48% vs. 33%, p = 0.018 and 47% vs. 31%, p = 0.001, respectively). In multivariate analysis, the rs16944 CC genotype was independently associated with HCC (OR = 6.44 [95% CI 1.50-27.59] p = 0.012). The haplotype, including rs1143623 TT and rs16944 CC, was a risk factor for HCC development (OR = 1.55 [95% CI 1.04-2.32] p = 0.031). Conclusions: We identified an association of common IL-1β SNPs with HBV-related HCC in a Caucasian population. The effect was independent of the phases of chronic HBV infection, which are currently regarded as important HCC risk factors.
Keywords: liver cancer; proinflammatory cytokine; risk variant.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.Infect Genet Evol. 2014 Dec;28:201-9. doi: 10.1016/j.meegid.2014.09.032. Epub 2014 Oct 2. Infect Genet Evol. 2014. PMID: 25281206
-
Association of Interleukin-1β and Gene Polymorphisms with Liver Pathogenesis in Hepatitis B Virus Infection among Eastern Indian Population.J Clin Exp Hepatol. 2013 Dec;3(4):281-7. doi: 10.1016/j.jceh.2013.11.006. Epub 2013 Dec 4. J Clin Exp Hepatol. 2013. PMID: 25755515 Free PMC article.
-
Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population.Infect Genet Evol. 2014 Oct;27:375-81. doi: 10.1016/j.meegid.2014.08.021. Epub 2014 Aug 27. Infect Genet Evol. 2014. PMID: 25173083
-
Chronic hepatitis B virus infection in Asian countries.J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. doi: 10.1046/j.1440-1746.2000.0150121356.x. J Gastroenterol Hepatol. 2000. PMID: 11197043 Review.
-
What can we learn from hepatitis B virus clinical cohorts?Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Liver Int. 2015. PMID: 25529093 Review.
Cited by
-
Effect of genetic polymorphisms of interleukin-1 beta on the microscopic portal vein invasion and prognosis of hepatocellular carcinoma.J Hepatobiliary Pancreat Sci. 2024 Aug;31(8):528-536. doi: 10.1002/jhbp.12009. Epub 2024 May 26. J Hepatobiliary Pancreat Sci. 2024. PMID: 38798075 Free PMC article.
-
Multifunctional roles of inflammation and its causative factors in primary liver cancer: A literature review.World J Hepatol. 2023 Dec 27;15(12):1258-1271. doi: 10.4254/wjh.v15.i12.1258. World J Hepatol. 2023. PMID: 38223416 Free PMC article. Review.
References
-
- Galle P.R., Forner A., Llovet J.M., Mazzaferro V., Piscaglia F., Raoul J.L., Schirmacher P., Vilgrain V., European Association for the Study of the Liver EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol. 2018;69:182–236. doi: 10.1016/j.jhep.2018.03.019. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources